Ts03 Inc (TSTIF) 2.4807 $TSTIF
TSO3 to Present at the 5th Annual Liolios Gateway Conference on September 7th, 2016
PR Newswire - Wed Aug 24, 9:30AM CDT
TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"
, an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel San Francisco.
TOS.TO: 3.24 (unch)
TSO3 Reports Second Quarter 2016 Results
PR Newswire - Wed Aug 03, 5:30AM CDT
Repeats Record Shipments, Re-engineers Facilities and Receives Industry-Changing Regulatory Clearances
TOS.TO: 3.24 (unch)
TSO3 Responds to U.S. Regulators on Extended Claims and Provides Operations Update
PR Newswire - Wed Jun 01, 4:00PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to a previously announced request for additional information by the U.S. Food and Drug Administration (the FDA) and that it has substantially completed its improvements to its manufacturing facility in Québec.
TOS.TO: 3.24 (unch)
Canadian Journal of Infection Control to Publish Paper on TSO3's STERIZONE® VP4 Sterilizer
PR Newswire - Wed May 18, 1:36PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that a peer-reviewed paper describing the Company's STERIZONE® VP4 Sterilizer has been accepted for publication in the Canadian Journal of Infection Control (CJIC). The paper entitled "The First Dual-Sterilant Low-Temperature Sterilization System" will appear in an upcoming issue of the publication.
TOS.TO: 3.24 (unch)
TSO3 announces the Results of the Votes from its Annual and Special Meeting of the Shareholders
PR Newswire - Thu May 05, 3:02PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated March 22, 2016, were elected as directors of TSO3 Inc. In addition, all other proposals submitted by management were approved.
TOS.TO: 3.24 (unch)
TSO3 Reports Record First Quarter 2016 Results
PR Newswire - Wed May 04, 5:30AM CDT
Commercial Rollout Drives Revenues of US$3.1 Million and Gross Profit of US$1.1 Million
TOS.TO: 3.24 (unch)
TSO3 to Report First Quarter 2016 Results and Hold Annual General and Special Meeting of Shareholders on Wednesday, May 4, 2016
PR Newswire - Tue Apr 26, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will report its first quarter 2016 financial results ended March 31, 2016 via press release on Wednesday, May 4, 2016 before the market opens.
TOS.TO: 3.24 (unch)
TSO3 to Present at Bloom Burton & Co. Healthcare Investor Conference on May 2, 2016
PR Newswire - Mon Apr 18, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at Bloom Burton & Co. Healthcare Investor Conference being held on May 2-3, 2016 at the Sheraton Centre Toronto Hotel in Toronto, Ontario.
TOS.TO: 3.24 (unch)
TSO3 Appoints Harold R. Tessman as COO
PR Newswire - Wed Jan 27, 5:30AM CST
TSO3 Inc. (TSX: TOS), a leader in low-temperature medical device sterilization, has appointed Harold R. Tessman to the new position of chief operating officer.
TOS.TO: 3.24 (unch)
TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
PR Newswire - Tue Dec 22, 6:00AM CST
Company Submits Required Documentation Seeking Clearance to Extend Sterilization Claims to Include up to Eight Channels in a Single Device for its STERIZONE® VP4 Sterilizer - an Industry First
TOS.TO: 3.24 (unch)
TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
PR Newswire - Mon Dec 21, 3:37PM CST
Company Notifies Suppliers and Accelerates Workforce Recruitment in Canada and the United States
TOS.TO: 3.24 (unch)
TSO3 Appoints Glen Kayll as Chief Financial Officer
PR Newswire - Fri Dec 18, 6:00AM CST
Seasoned Public Company CFO With Financial and Cross Border Listing Experience to Join Management Team
TOS.TO: 3.24 (unch)
TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization
PR Newswire - Thu Dec 17, 6:00AM CST
STERIZONE® VP4 Sterilizer Validated to Sterilize Complex, Multi-Channel Endoscopic Devices
TOS.TO: 3.24 (unch)
TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
PR Newswire - Wed Nov 25, 10:40AM CST
US$7.5 Million Up-Front License Fees and Performance Minimums Highlights of Agreement
TOS.TO: 3.24 (unch)
IIROC Trade Halt - TSO3 Inc.
Newsfile Corp - Wed Nov 25, 8:36AM CST
The following issues have been halted by IIROC:
TSO3 Appoints Steve West to Board of Directors
PR Newswire - Tue Nov 10, 9:14AM CST
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has appointed Steve West to the Company's board of directors.
TOS.TO: 3.24 (unch)
TSO3 Reports Third Quarter 2015 Financial Results
PR Newswire - Wed Nov 04, 6:00AM CST
Q3 Revenues Ramp to $1.2 Million, Driven by U.S. Commercial Rollout of STERIZONE® VP4 Sterilizer Build-Out of U.S. Distribution and Customer Support Facility Complete
TOS.TO: 3.24 (unch)
TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 Sterilizer
PR Newswire - Mon Oct 26, 7:30AM CDT
STERIZONE® VP4 Sterilizer Achieves Industry First: Terminally Sterilize up to Eight Channels in a Single Device
TOS.TO: 3.24 (unch)
TSO3 Sets Third Quarter 2015 Earnings Call for Wednesday, November 4, 2015 at 10:30 a.m. ET
PR Newswire - Wed Oct 21, 7:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, November 4, 2015 at 10:30 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2015. Financial results will be issued in a press release prior to the call.
TOS.TO: 3.24 (unch)
Global Medical Devices: Quarterly Investments Review Featuring the Most Recent 200 Business Transactions
M2 - Tue Oct 20, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mqnnl4/global_medical) has announced the addition of the "Global Medical Devices: Quarterly Investments Review " report to their offering. The 'Global Medical Devices: Quarterly Investments Review report' presents the most recent 200 business transactions between the global medical devices/technology/supplies companies are identified, segregated and analyzed to highlight the scope of investments in different sub-industry sectors. Medical device companies are expected to realign their business structures and strategies to compete in the changing global environment (such as growth of emerging markets, health care reform and cost containment). Anticipated changes include company restructuring as well as an increased reliance on strategic alliances and outsourcing for marketing, distribution, research and manufacturing activities. In this context, the author which has been providing company and financial information globally since two decades, brings out Global Medical Devices: Quarterly Investments Review report for global medical devices/technology/supplies companies. Report Highlights: - A guidance business tool which helps the investors in the global medical devices/technology/supplies industry to assess the investment opportunities for the coming months - Helps the investors to familiarize with the existing investment trends in the global medical devices/technology/supplies industry - Helps the global medical devices/technology/supplies companies to know the prevailing sub-industry trends in the global medical devices/technology/supplies business transactions - Presents the key investment strategies applied by the global medical devices/technology/supplies companies - Highlights the favored countries for the deals by the global medical devices/technology/supplies companies - Useful information on trade facilitators' activities to accelerate global medical devices/technology/supplies commerce - Summarizes the recent regulatory developments that are likely to affect the trade approaches of the global medical devices/technology/supplies industry - Summarizes new policies of various governments in global medical devices/technology/supplies industry and its impact on investments globally - Provides at one glance the listing of important transactions across the global medical devices/ technology/supplies sector Companies Mentioned - Simavita Ltd (Australia) - Solborn Incorporated (South Korea) - Sorin SpA (Italy) - Strand Life Sciences Private Limited (India) - Stratec Biomedical AG (Germany) - Straumann Holding AG (Switzerland) - Sunshine Holdings PLC (Sri Lanka) - Sysmex Corporation (Japan) - Thermo Fisher Scientific Inc (United States) - Tornier NV (Netherlands) - Toumaz Limited (United Kingdom) - TSO3 Inc (Canada) - Varian Medical Systems, Inc. (United States) - Vivoline Medical AB (Sweden) - Voxel SA (Poland) - William Demant Holding (Denmark) - Wound Management Technologies, Inc. (United States) - Yamato Scientific Co, Ltd (Japan) - Zecotek Photonics Inc (Canada) - Zhejiang DA Diagnostics Co Ltd (China) For more information visit http://www.researchandmarkets.com/research/mq...al_medical
VAR: 98.17 (-0.33)
TSO3 to Present at the 5th Annual Liolios Gateway Conference on September 7th, 2016
PR Newswire - Wed Aug 24, 9:30AM CDT
TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"
, an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel San Francisco. TOS.TO: 3.24 (unch)
TSO3 Reports Second Quarter 2016 Results
PR Newswire - Wed Aug 03, 5:30AM CDT
Repeats Record Shipments, Re-engineers Facilities and Receives Industry-Changing Regulatory Clearances
TOS.TO: 3.24 (unch)
TSO3 Responds to U.S. Regulators on Extended Claims and Provides Operations Update
PR Newswire - Wed Jun 01, 4:00PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to a previously announced request for additional information by the U.S. Food and Drug Administration (the FDA) and that it has substantially completed its improvements to its manufacturing facility in Québec.
TOS.TO: 3.24 (unch)
Canadian Journal of Infection Control to Publish Paper on TSO3's STERIZONE® VP4 Sterilizer
PR Newswire - Wed May 18, 1:36PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that a peer-reviewed paper describing the Company's STERIZONE® VP4 Sterilizer has been accepted for publication in the Canadian Journal of Infection Control (CJIC). The paper entitled "The First Dual-Sterilant Low-Temperature Sterilization System" will appear in an upcoming issue of the publication.
TOS.TO: 3.24 (unch)
TSO3 announces the Results of the Votes from its Annual and Special Meeting of the Shareholders
PR Newswire - Thu May 05, 3:02PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated March 22, 2016, were elected as directors of TSO3 Inc. In addition, all other proposals submitted by management were approved.
TOS.TO: 3.24 (unch)
TSO3 Reports Record First Quarter 2016 Results
PR Newswire - Wed May 04, 5:30AM CDT
Commercial Rollout Drives Revenues of US$3.1 Million and Gross Profit of US$1.1 Million
TOS.TO: 3.24 (unch)
TSO3 to Report First Quarter 2016 Results and Hold Annual General and Special Meeting of Shareholders on Wednesday, May 4, 2016
PR Newswire - Tue Apr 26, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will report its first quarter 2016 financial results ended March 31, 2016 via press release on Wednesday, May 4, 2016 before the market opens.
TOS.TO: 3.24 (unch)
TSO3 to Present at Bloom Burton & Co. Healthcare Investor Conference on May 2, 2016
PR Newswire - Mon Apr 18, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at Bloom Burton & Co. Healthcare Investor Conference being held on May 2-3, 2016 at the Sheraton Centre Toronto Hotel in Toronto, Ontario.
TOS.TO: 3.24 (unch)
TSO3 Appoints Harold R. Tessman as COO
PR Newswire - Wed Jan 27, 5:30AM CST
TSO3 Inc. (TSX: TOS), a leader in low-temperature medical device sterilization, has appointed Harold R. Tessman to the new position of chief operating officer.
TOS.TO: 3.24 (unch)
TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
PR Newswire - Tue Dec 22, 6:00AM CST
Company Submits Required Documentation Seeking Clearance to Extend Sterilization Claims to Include up to Eight Channels in a Single Device for its STERIZONE® VP4 Sterilizer - an Industry First
TOS.TO: 3.24 (unch)
TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
PR Newswire - Mon Dec 21, 3:37PM CST
Company Notifies Suppliers and Accelerates Workforce Recruitment in Canada and the United States
TOS.TO: 3.24 (unch)
TSO3 Appoints Glen Kayll as Chief Financial Officer
PR Newswire - Fri Dec 18, 6:00AM CST
Seasoned Public Company CFO With Financial and Cross Border Listing Experience to Join Management Team
TOS.TO: 3.24 (unch)
TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization
PR Newswire - Thu Dec 17, 6:00AM CST
STERIZONE® VP4 Sterilizer Validated to Sterilize Complex, Multi-Channel Endoscopic Devices
TOS.TO: 3.24 (unch)
TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
PR Newswire - Wed Nov 25, 10:40AM CST
US$7.5 Million Up-Front License Fees and Performance Minimums Highlights of Agreement
TOS.TO: 3.24 (unch)
IIROC Trade Halt - TSO3 Inc.
Newsfile Corp - Wed Nov 25, 8:36AM CST
The following issues have been halted by IIROC:
TSO3 Appoints Steve West to Board of Directors
PR Newswire - Tue Nov 10, 9:14AM CST
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has appointed Steve West to the Company's board of directors.
TOS.TO: 3.24 (unch)
TSO3 Reports Third Quarter 2015 Financial Results
PR Newswire - Wed Nov 04, 6:00AM CST
Q3 Revenues Ramp to $1.2 Million, Driven by U.S. Commercial Rollout of STERIZONE® VP4 Sterilizer Build-Out of U.S. Distribution and Customer Support Facility Complete
TOS.TO: 3.24 (unch)
TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 Sterilizer
PR Newswire - Mon Oct 26, 7:30AM CDT
STERIZONE® VP4 Sterilizer Achieves Industry First: Terminally Sterilize up to Eight Channels in a Single Device
TOS.TO: 3.24 (unch)
TSO3 Sets Third Quarter 2015 Earnings Call for Wednesday, November 4, 2015 at 10:30 a.m. ET
PR Newswire - Wed Oct 21, 7:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, November 4, 2015 at 10:30 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2015. Financial results will be issued in a press release prior to the call.
TOS.TO: 3.24 (unch)
Global Medical Devices: Quarterly Investments Review Featuring the Most Recent 200 Business Transactions
M2 - Tue Oct 20, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mqnnl4/global_medical) has announced the addition of the "Global Medical Devices: Quarterly Investments Review " report to their offering. The 'Global Medical Devices: Quarterly Investments Review report' presents the most recent 200 business transactions between the global medical devices/technology/supplies companies are identified, segregated and analyzed to highlight the scope of investments in different sub-industry sectors. Medical device companies are expected to realign their business structures and strategies to compete in the changing global environment (such as growth of emerging markets, health care reform and cost containment). Anticipated changes include company restructuring as well as an increased reliance on strategic alliances and outsourcing for marketing, distribution, research and manufacturing activities. In this context, the author which has been providing company and financial information globally since two decades, brings out Global Medical Devices: Quarterly Investments Review report for global medical devices/technology/supplies companies. Report Highlights: - A guidance business tool which helps the investors in the global medical devices/technology/supplies industry to assess the investment opportunities for the coming months - Helps the investors to familiarize with the existing investment trends in the global medical devices/technology/supplies industry - Helps the global medical devices/technology/supplies companies to know the prevailing sub-industry trends in the global medical devices/technology/supplies business transactions - Presents the key investment strategies applied by the global medical devices/technology/supplies companies - Highlights the favored countries for the deals by the global medical devices/technology/supplies companies - Useful information on trade facilitators' activities to accelerate global medical devices/technology/supplies commerce - Summarizes the recent regulatory developments that are likely to affect the trade approaches of the global medical devices/technology/supplies industry - Summarizes new policies of various governments in global medical devices/technology/supplies industry and its impact on investments globally - Provides at one glance the listing of important transactions across the global medical devices/ technology/supplies sector Companies Mentioned - Simavita Ltd (Australia) - Solborn Incorporated (South Korea) - Sorin SpA (Italy) - Strand Life Sciences Private Limited (India) - Stratec Biomedical AG (Germany) - Straumann Holding AG (Switzerland) - Sunshine Holdings PLC (Sri Lanka) - Sysmex Corporation (Japan) - Thermo Fisher Scientific Inc (United States) - Tornier NV (Netherlands) - Toumaz Limited (United Kingdom) - TSO3 Inc (Canada) - Varian Medical Systems, Inc. (United States) - Vivoline Medical AB (Sweden) - Voxel SA (Poland) - William Demant Holding (Denmark) - Wound Management Technologies, Inc. (United States) - Yamato Scientific Co, Ltd (Japan) - Zecotek Photonics Inc (Canada) - Zhejiang DA Diagnostics Co Ltd (China) For more information visit http://www.researchandmarkets.com/research/mq...al_medical
VAR: 98.17 (-0.33)
